| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $2.36 ▲ +1.77% | wingi | $2.30 ▼ -0.74% | Sesuk Neumora Therapeutics Inc. Common Stock (NMRA) persiyapan wis anchored kanggo $2.32 lan target $2.36 (+1.77%). Waca sing cedhak yaiku munggah; nonton $2.39 / $2.25 amarga volatilitas sing diwujudake saben dina babagan 8.00%. |
Sesuk Neumora Therapeutics Inc. Common Stock (NMRA) persiyapan wis anchored kanggo $2.32 lan target $2.36 (+1.77%). Waca sing cedhak yaiku munggah; nonton $2.39 / $2.25 amarga volatilitas sing diwujudake saben dina babagan 8.00%. | ||||
| Minggu | $2.45 ▲ +5.50% | Minggu kepungkur | $2.27 ▼ -2.31% | Model 7 dina Neumora Therapeutics Inc. Common Stock pindhah saka $2.27 menyang $2.45 (+5.50%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $2.39 / $2.25 prakara luwih saka siji obah. |
Model 7 dina Neumora Therapeutics Inc. Common Stock pindhah saka $2.27 menyang $2.45 (+5.50%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $2.39 / $2.25 prakara luwih saka siji obah. | ||||
| wulan | $2.59 ▲ +11.71% | Wulan kepungkur | $2.21 ▼ -4.92% | Target 1 wulan Neumora Therapeutics Inc. Common Stock yaiku $2.59 (+11.71%), dibandhingake karo referensi langsung ing cedhak $2.32. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Neumora Therapeutics Inc. Common Stock yaiku $2.59 (+11.71%), dibandhingake karo referensi langsung ing cedhak $2.32. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $2.81 ▲ +21.03% | Taun kepungkur | $2.12 ▼ -8.83% | Skenario 1 taun Neumora Therapeutics Inc. Common Stock nuduhake $2.81 (+21.03%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Neumora Therapeutics Inc. Common Stock nuduhake $2.81 (+21.03%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $3.31 ▲ +42.86% | 5 Taun kepungkur | $1.90 ▼ -18.00% | Tampilan 5 taun Neumora Therapeutics Inc. Common Stock yaiku $3.31 (+42.86%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Neumora Therapeutics Inc. Common Stock yaiku $3.31 (+42.86%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $2.32 | agêng |
| Ganti saben dina | +5.94% | Ndhuwur |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 70% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $2.32 | Ganti saben dina | +5.94% |
| Pasar Kab | $423.84M | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.